I

Intra-Cellular TherapiesPharmaceutical Manufacturing · 1001-5000 · B2B contacts & data

61 Decision makers
+1 New (6 months)
5,000 Employees
$681M Revenue
2002 Founded

Decision Makers at Intra-Cellular Therapies

Total identified

61 decision makers identified 1 C-Level 13 VP 47 Heads

New decision makers — last 6 months

+1 a strong signal to time your outreach 1 Heads
Preview available contacts
Decision maker Email Phone

Create a free Zeliq account to access their verified emails and direct phone numbers.

See 61 decision makers on Zeliq →

Organizational Chart of Intra-Cellular Therapies

Roles identified within Intra-Cellular Therapies's leadership team, based on public professional data.

Intra-Cellular Therapies's Full Organizational Chart

Loading…

Get their contacts on Zeliq →

Job title Department People Action

Team Structure headcount by department

Sales
320
Research
47
General Management
38
Medical
36
Finance
15
Marketing
9
Other
9
Operations
8

Funding

Last round Other · $500M
Total funding $2.3B (19 rounds)
Corporate Round N/A Jan 2002
Series A $3M May 2002
Series B $8M Jan 2006
Grant $730K Dec 2006
Series C $8M Oct 2007
Series C $5M Mar 2010
Debt Financing $15M May 2013
Secondary Market $60M Sep 2013
Post-IPO Equity N/A Jan 2014
Post-IPO Equity $121M Mar 2015
Post-IPO Equity $345M Sep 2015
Grant $348K Jan 2016
Post-IPO Equity $162M Oct 2017
Grant $3M Jan 2019
Post-IPO Equity $295M Jan 2020
Post-IPO Equity $350M Sep 2020
Post-IPO Equity $434M Jan 2022
Post-IPO Debt $500M Apr 2024
Seed Round N/A

Companies similar to Intra-Cellular Therapies

Latest news at Intra-Cellular Therapies

  1. Appointment

    New Msl Field Director - Central appointed — Sales

    Get email and phone via Zeliq →

About Intra-Cellular Therapies

Intra-Cellular Therapies is a Pharmaceutical Manufacturing company, headquartered in bedminster, United States. Established in 2002, it has a workforce of roughly 5,000 people. Intra-Cellular Therapies belongs to the Manufacturing sector, with a specific positioning on Pharmaceutical Manufacturing. Its customer base is mainly professional: Intra-Cellular Therapies operates on a B2B model. Intra-Cellular Therapies has raised funding across 19 rounds totalling $2.3B. The company generates approximately $681M in annual revenue. This profile compiles key information about Intra-Cellular Therapies, including industry, size, location, business signals, and B2B contacts, to help sales teams qualify the account and identify the right decision makers before reaching out.

Activity & Market

Intra-Cellular Therapies operates in the Pharmaceutical Manufacturing segment, part of the broader Manufacturing sector. As a B2B company, Intra-Cellular Therapies primarily serves business clients and professional organisations. In terms of structure, it is registered as “Public company”.

How to prospect Intra-Cellular Therapies's departments

Sales

This is where the company's largest headcount sits (320 people). These profiles handle outreach daily and respond well to concrete pitches about pipeline, productivity and prospecting tooling.

Research

The company's second-largest department (47 people). Data quality and reproducibility are core concerns: a strong angle if your offer touches either.

General Management

A team of 38 people. A good executive approach often starts lower in the organisation: build an internal champion before going top-down.

Medical

This department counts 36 people. Regulatory constraints and protocols shape everything here: show you understand their compliance context before pitching.

Finance

15 people work in this department. These decision makers arbitrate budgets: a well-quantified business case is your best door opener.

Marketing

A team of 9 people. Campaign performance and attribution are constant topics: a good angle to open the conversation.

FAQ Intra-Cellular Therapies

What industry does Intra-Cellular Therapies operate in?

Intra-Cellular Therapies operates in the Pharmaceutical Manufacturing industry, specifically in the Manufacturing category.

How many employees does Intra-Cellular Therapies have?

Intra-Cellular Therapies has approximately 5,000 employees (in the 1001-5000 range). This figure is an estimate to help qualify the account, not a legally certified number.

How do I find contacts at Intra-Cellular Therapies?

With Zeliq, you can find the right decision makers at Intra-Cellular Therapies, get their verified emails and direct phone numbers, and engage them through targeted multichannel sequences.

Where is Intra-Cellular Therapies headquartered?

Intra-Cellular Therapies is headquartered in bedminster, United States.

What is the organizational chart of Intra-Cellular Therapies?

Based on public professional data, Intra-Cellular Therapies's organizational chart includes roles such as Chief Medical Officer, Executive Vice President, Senior Vice President, Head of Sales, Vice President Medical Affairs, Area Sales Director, Director, Global Site Management. Zeliq lets you find the verified contact details behind each of these roles.

Which decision makers recently joined Intra-Cellular Therapies?

In the last 6 months, Intra-Cellular Therapies appointed new decision makers including Msl Field Director - Central. Newly appointed leaders typically review tools and vendors early on — their verified contacts are available on Zeliq.

Why use this data before prospecting Intra-Cellular Therapies?

With Intra-Cellular Therapies's firmographics and business signals at hand, you can prioritise the account, personalise your approach, and contact the right people straight away.